Ansaldo STS SpA:企業の戦略・SWOT・財務情報

◆英語タイトル:Ansaldo STS SpA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C11793
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:建設・建築
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Ansaldo STS SpA – Strategy, SWOT and Corporate Finance Report
Summary

Ansaldo STS SpA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Ansaldo STS S.p.A. (Ansaldo) is engaged in the design, manufacturing, installation and maintenance of components of railways and metro lines for both passenger traffic and goods transport. The group operates in railway and urban transport systems markets and provides turnkey solutions as a general contractor, and integrated transport systems with its signaling products. It also provides engineering expertise as an IT system enabler and provider of other subsystems. The group operates globally with major presence in Central and Eastern Europe, Middle East, Western Europe, North Africa, the Americas and Asia Pacific. It is headquartered in Genoa, Italy.

Scope

- Detailed information on Ansaldo STS SpA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ansaldo STS SpA in the form of a SWOT analysis
- An in-depth view of the business model of Ansaldo STS SpA including a breakdown and examination of key business segments
- Intelligence on Ansaldo STS SpA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ansaldo STS SpA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Ansaldo STS SpA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ansaldo STS SpA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Ansaldo STS SpA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Ansaldo STS SpA: Company Overview 9
Ansaldo STS SpA: Overview and Key Facts 9
Ansaldo STS SpA: Overview 9
Ansaldo STS SpA: Key Facts 9
Ansaldo STS SpA: Key Employees 10
Ansaldo STS SpA: Key Employee Biographies 12
Ansaldo STS SpA: Major Products and Services 17
Ansaldo STS SpA: Company History 18
Ansaldo STS SpA: Management Statement 22
Ansaldo STS SpA: Locations and Subsidiaries 23
Ansaldo STS SpA: Key Competitors 24
Ansaldo STS SpA: Company Analysis 25
Ansaldo STS SpA: Business Description 25
Ansaldo STS SpA: SWOT Analysis 27
Ansaldo STS SpA: SWOT Overview 27
Ansaldo STS SpA: Strengths 27
Ansaldo STS SpA: Weaknesses 28
Ansaldo STS SpA: Opportunities 28
Ansaldo STS SpA: Threats 29
Ansaldo STS SpA: Corporate Financial Deals Activity 30
Ansaldo STS SpA: Financial Deals Overview 30
Ansaldo STS SpA: Top Deals 2014 – 2018YTD* 32
Ansaldo STS SpA: Private Equity and Ownership 33
Ansaldo STS SpA: Recent Developments 34
Ansaldo STS SpA: News and Events Summary 34
Ansaldo STS SpA: Contracts 39
Ansaldo STS SpA: Corporate Governance 41
Ansaldo STS SpA: Financial Deals 41
Ansaldo STS SpA: Strategy and Operations 42
Appendix 44
Contact Us 44
Methodology 44
About MarketLine 45

List of Tables
Table 1: Ansaldo STS SpA: Key Facts
Table 2: Ansaldo STS SpA: Key Employees
Table 3: Ansaldo STS SpA: Company History
Table 4: Ansaldo STS SpA: Locations and Subsidiaries
Table 5: Ansaldo STS SpA: Key Competitors
Table 6: Ansaldo STS SpA: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Ansaldo STS SpA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Ansaldo STS SpA: Top Deals 2014 - 2018YTD*
Table 9: Ansaldo STS SpA: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 10: Ansaldo STS SpA: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 11: Ansaldo STS SpA: News and Events Summary
Table 12: Ansaldo STS SpA: Contracts
Table 13: Ansaldo STS SpA: Corporate Governance
Table 14: Ansaldo STS SpA: Financial Deals
Table 15: Ansaldo STS SpA: Strategy and Operations

List of Figures
Figure 1: Ansaldo STS SpA: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Ansaldo STS SpA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Ansaldo STS SpA: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 4: Ansaldo STS SpA: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Ansaldo STS SpA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hetero Drugs Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Hetero Drugs Ltd (Hetero) is a manufacturer of active pharmaceutical ingredients, intermediate chemicals and finished dosages. The company specializes in process chemistry, API manufacturing, formulation development, manufacturing and commercialization of bio-generics, and also offers custom …
  • Waters Corporation (WAT)-医療機器分野:企業M&A・提携分析
    Summary Waters Corporation (Waters) is an analytical instrument manufacturing company. It carries out the design, production, commercialization and servicing of analytical technologies such as high performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), chromatograp …
  • Recylex SA:企業の戦略・SWOT・財務情報
    Recylex SA - Strategy, SWOT and Corporate Finance Report Summary Recylex SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Sinclair Broadcast Group, Inc.:企業の戦略・SWOT・財務分析
    Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Investor AB (INVE B):企業の財務・戦略的SWOT分析
    Investor AB (INVE B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Vattenfall AB:企業の戦略的SWOT分析
    Vattenfall AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Ultra Clean Holdings Inc (UCTT):企業の財務・戦略的SWOT分析
    Summary Ultra Clean Holdings Inc (UCH) is a developer and supplier of critical systems and subsystems. The company’s products include precision robotic solutions, gas delivery systems, industrial and automation production equipment, chemical delivery modules, top-plate assemblies, wafer cleaning sub …
  • TOWER Limited:企業の戦略・SWOT・財務情報
    TOWER Limited - Strategy, SWOT and Corporate Finance Report Summary TOWER Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Y.S.P. Southeast Asia Holding Berhad (YSPSAH):企業の財務・戦略的SWOT分析
    Y.S.P. Southeast Asia Holding Berhad (YSPSAH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Actavalon Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Actavalon Inc (Actavalon) is an oncology-focused company, which develops small molecule medicines targeting two basic cancer pathways, namely, the p53 tumor suppressor pathway and the aryl hydrocarbon receptor (AhR) pathway. It is developing small molecules that can stabilize the mutant p53 …
  • Borders & Southern Petroleum plc (BOR):企業の財務・戦略的SWOT分析
    Summary Borders & Southern Petroleum Plc (Borders & Southern Petroleum) is an oil and gas company that offers exploration and development of hydrocarbons. The company holds interests in three production licenses in the Falkland Islands located south-east of the Islands. Its production licenses provi …
  • Campanile UK Ltd:企業の戦略・SWOT・財務分析
    Campanile UK Ltd - Strategy, SWOT and Corporate Finance Report Summary Campanile UK Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Theranyx Sarl:製薬・医療:M&Aディール及び事業提携情報
    Summary Theranyx Sarl is a bio technology company that develops novel therapeutic drugs and solutions to treat cancer. The company’s main line business involved in generation of functional antibodies to target GPCRs and ion channel receptors. Its antibodies named as Therabodies has scope in target v …
  • Exillon Energy Plc (EXI):企業の財務・戦略的SWOT分析
    Summary Exillon Energy Plc (Exillon) is an oil exploration and production company. The company explores, produces and develops crude oil. Its services include drilling, exploration, appraisal, development, operations, management, and production services. Exillon’s operating assets are located in two …
  • 1-800-FLOWERS.COM, Inc.:企業の戦略・SWOT・財務分析
    1-800-FLOWERS.COM, Inc. - Strategy, SWOT and Corporate Finance Report Summary 1-800-FLOWERS.COM, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Fairfax Financial Holdings Limited:企業のM&A・事業提携・投資動向
    Fairfax Financial Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fairfax Financial Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • hVIVO Plc (HVO):企業の財務・戦略的SWOT分析
    Summary hVIVO Plc (hVIVO), formerly Retroscreen Virology Ltd is a biopharma company that develops human-based analytical platform to accelerate drug discovery and development. The company enables organisations to discover drugs and diagnostics and accelerate new product development. It uses human di …
  • Oceanteam ASA (OTS):企業の財務・戦略的SWOT分析
    Oceanteam ASA (OTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Top Image Systems Ltd. (TISA):企業の財務・戦略的SWOT分析
    Top Image Systems Ltd. (TISA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Orexo AB (ORX):製薬・医療:M&Aディール及び事業提携情報
    Summary Orexo AB (Orexo) is a specialty pharmaceutical company that focuses on the research, formulation, development, registration and commercialization of drugs. The company's commercial product portfolio consists of Abstral, Edluar and Zubsolv. its pipeline candidates comprise OX51 for procedure- …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆